Clinical Trials

Title   AHEP0731 Treatment of Children with All Stages of Hepatoblastoma with Temsirolimus (IND#122782, NSC#683864) Added to High Risk Stratum Treatment A Phase III Study, An Intergroup Study for Participation by COG and the Japanese Study Group for Pediatric
Description   The primary goal of this study is to show that a risk-based treatment approach will maintain or improve EFS, decrease acute and long-term chemotherapy toxicity, and identify new agents for the treatment of children with hepatoblastoma.
IRB Number   17-157
Treatment   Pediatric Oncology- Hepatoblastoma
Status   Active
Principal Name   Felicia L. Wilson, , M.D.
Contact Name   Andretta McCovey

Email Newsletters

Connect With Us